Next Article in Journal
Cellular and Humoral Immune Responses to Vaccination for COVID-19 Are Negatively Impacted by Senescent T Cells: A Case Report
Next Article in Special Issue
Immunologic Response to SARS-CoV-2 Vaccination in Pediatric Kidney Transplant Recipients: A Systematic Review and Meta-Analysis
Previous Article in Journal
Low Vaccine Coverage and Factors Associated with Incomplete Childhood Immunization in Racial/Ethnic Minorities and Rural Groups, Central Brazil
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

COVID-19 Vaccine Refusal and Delay among Adults in Italy: Evidence from the OBVIOUS Project, a National Survey in Italy

by
Davide Gori
1,
Angelo Capodici
1,
Giusy La Fauci
1,*,
Marco Montalti
1,
Aurelia Salussolia
1,
Giorgia Soldà
1,
Zeno Di Valerio
1,
Francesca Scognamiglio
1,
Maria Pia Fantini
1,
Julie Leask
2,3,
Heidi J. Larson
4,5,
Stefania Profeti
6,
Federico Toth
6,
Jacopo Lenzi
1 and
on behalf of the other researchers of the OBVIOUS BOARD
1
Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy
2
Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia
3
Sydney Infectious Diseases Institute, Westmead, NSW 2145, Australia
4
Institute for Health Metrics & Evaluation (IHME), University of Washington, Seattle, WA 98105, USA
5
London School of Hygiene and Tropical Medicine (LSHTM), London WC1E 7HT, UK
6
Department of Political and Social Sciences, University of Bologna, 40125 Bologna, Italy
*
Author to whom correspondence should be addressed.
Observatory on Vaccine Hesitancy in Italy—Online UniBo Surveys (Michele Conversano, Claudio Costantino, Mirko Degli Esposti, Andrea Grignolio, Anna Odone, Daniel Remondini, Francesco Vitale).
Vaccines 2023, 11(4), 839; https://doi.org/10.3390/vaccines11040839
Submission received: 7 March 2023 / Revised: 11 April 2023 / Accepted: 12 April 2023 / Published: 13 April 2023

Abstract

:
Background: Vaccine hesitancy was defined by the World Health Organization (WHO) in 2019 as a major threat to global health. In Italy, reluctance to receive vaccines is a widespread phenomenon that was amplified during the COVID-19 pandemic by fear and mistrust in government. This study aims to depict different profiles and characteristics of people reluctant to vaccinate, focusing on the drivers of those who are in favor of and those who are opposed to receiving the COVID-19 vaccine. Methods: A sample of 10,000 Italian residents was collected. A survey on COVID-19 vaccination behavior and possible determinants of vaccine uptake, delay, and refusal was administered to participants through a computer-assisted web interviewing method. Results: In our sample, 83.2% stated that they were vaccinated as soon as possible (“vaccinators”), 8.0% delayed vaccination (“delayers”), and 6.7% refused to be vaccinated (“no-vaccinators”). In general, the results show that being female, aged between 25 and 64, with an education level less than a high school diploma or above a master’s degree, and coming from a rural area were characteristics significantly associated with delaying or refusing COVID-19 vaccination. In addition, it was found that having minimal trust in science and/or government (i.e., 1 or 2 points on a scale from 1 to 10), using alternative medicine as the main source of treatment, and intention to vote for certain parties were characteristics associated with profiles of “delayers” or “no-vaccinators”. Finally, the main reported motivation for delaying or not accepting vaccination was fear of vaccine side effects (55.0% among delayers, 55.6% among no-vaccinators). Conclusion: In this study, three main profiles of those who chose to be vaccinated are described. Since those who are in favor of vaccines and those who are not usually cluster in similar sociodemographic categories, we argue that findings from this study might be useful to policy makers when shaping vaccine strategies and choosing policy instruments.

1. Introduction

The rich scientific literature on vaccine hesitancy and its multiple determinants dates back to the pre-COVID-19 era. The World Health Organization (WHO) listed vaccine hesitancy among the ten threats to global health of 2019 and re-defined it as a motivational state of being conflicted or opposed to vaccination [1,2]. Many researchers agree that vaccine hesitancy should not be thought of as a dichotomous variable (yes/no), but rather as a continuum [3,4,5,6,7,8] related both to the individual and the socio-political context in which he/she lives [9,10].
In order to highlight the different beliefs, motivations, and attitudes toward vaccines, some scholars have identified multiple (ideal–typical) “profiles”. In most cases, such psychological profiles have been suggested to define different types of parents with respect to childhood vaccinations. However, such profiles can also be used for adult vaccinations. Expressions, such as “immunization advocate” [11], “vaccine believer” [12], and “unquestioning acceptor” [13] have been used to define the profile of the most pro-vaccination individuals. On the other hand, labels, such as “unconvinced” [12], “rejecter” [14], or “refuser”, [13] have been proposed to identify individuals who are firmly opposed to vaccination. The profiles of the “worried” [11], the “cautious” [12], or the “hesitant” [13] correspond to those who—to varying degrees—are concerned about the adverse effects of vaccination. Some authors have identified as “late vaccinators” [13,14] or “fence-sitters” [4,11,15] those who intentionally postpone vaccination in order to gather more information and assess the effects of the vaccine on other individuals. Other authors have identified “calculator” or “free-rider” profiles [4,16] to classify those who decide whether or not to vaccinate on the basis of a rational calculation between individual costs and benefits.
Investigating ambivalence is inherently complex. Alas, to better understand this phenomenon, it is useful to juxtapose those who have not yet made a decision with those who have. Since data on procrastinators could potentially shed light on vaccine hesitancy as a whole, this study presents data on both those who are in favor of and those who are opposed to receiving the COVID-19 vaccine and expands the subject by analyzing those who are delaying and could therefore be defined as “hesitant”.
Hence, the aim of the present research was to create a specific focus on the different profiles and characteristics of vaccine-reluctant people by using a structured survey conducted on a large national sample of Italy’s demographics.

2. Materials and Methods

2.1. Study Design and Data Collection

This study was conducted as a cross-sectional computer-assisted web interviewing (CAWI) questionnaire. From 11 April to 29 May 2022, the professional online provider Dynata [17] surveyed 10,000 Italian citizens aged ≥18 years using a stratified sampling based on proportionate allocation by first-level NUTS (Nomenclature of Territorial Units for Statistics) statistical region of residence (Northwest, Northeast, Center, South, and Islands), gender, and age group.
The survey was designed to be completed in ~10 min and included 7 sections investigating demographics and living conditions, data on vaccination against influenza (the focus of this work), pneumococcus, varicella-zoster virus, rotavirus and human papillomavirus, political orientation, and attitudes toward SARS-CoV-2 vaccination, science, and alternative medicine
Data management of Dynata was performed in accordance with the General Data Protection Regulation of the European Union. The survey followed all requirements under Italian regulations.

2.2. Variables

Cognitive testing was conducted prior to full implementation, and feedback was used to revise the questionnaire. A total of 15 sociodemographic questions were included: gender; date of birth; region of residence; educational qualification; occupation; living arrangements; ability to pay necessary living expenses; problems with activities of daily living due to physical or mental disabilities; weight; height; suffering from chronic respiratory/cardiovascular disease/diabetes; place where most vaccinations were carried out; preferred place for vaccination; and friends’ and family members’ opinions on vaccination.
Respondents were then asked to indicate which of the following statements they most agreed with: (1) the government should make vaccines available and limit itself to providing information, without trying to influence individual choice; (2) the government should provide incentives for those who vaccinate, but not impose any obligations; (3) the government should provide penalties for those who decide not to vaccinate; and (4) in health emergencies, it is right for the government to mandate vaccination.
Questions on voting intention, trust in science (on an ordinal scale from 1 to 10), trust in government (on an ordinal scale from 1 to 10), behavior towards COVID-19 vaccination, reasons for delaying or refusing vaccination, and use of alternative medicines as the main source of treatment were also included.
The vaccine-specific sections were developed following the domains of the WHO BesD framework [1]: thoughts and feelings, social processes, motivation, practical issues, and vaccination. The questionnaire can be found in the Appendix A.
The data management was performed in accordance with the General Data Protection Regulation of the European Union. The survey experiment followed all requirements under Italian regulations.

2.3. Data

The survey was designed to record respondents’ behavior regarding COVID-19 vaccination on the one hand, and to obtain information on the possible determinants of vaccine delay and refusal on the other. Respondents to the questionnaire were asked to indicate which of the following four options represented their situation: (1) I got the vaccine immediately, as soon as it was my turn; (2) I voluntarily postponed vaccination; (3) I did not get the vaccine; (4) I am exempt from vaccination for medical reasons (official medical certification). Based on the answers to this question, it was then decided to divide the sample into three categories: “vaccinators”, “delayers”, and “non-vaccinators”. Study participants were also asked to indicate the main reasons (three options ranked by importance) behind their decisions about vaccination, drawing up the various options on the basis of the “5C Model” of the psychological drivers of vaccine hesitancy (confidence, complacency, constraints, [risk] calculation, and collective responsibility) [7].
Still concerning the determinants of vaccine uptake, delay, and refusal, questions were included to investigate both the main variables established in the literature (sociodemographic conditions, trust in institutions and science, use of alternative medicines) and variables concerning the political domain (politics and policy). Moreover, knowing that perception and utilization of health services may change according to urbanization [18,19], municipalities of residence were subdivided into rural areas (sparsely populated areas), towns or suburbs (intermediate density areas), and cities (densely populated areas) using the Eurostat Degree of Urbanization (DEGURBA) classification system based on 2011 population grids and 2018 administrative boundaries.

2.4. Statistical Analysis

All data were summarized as counts and percentages and visualized with the aid of bar charts, pie charts, and thematic maps. To account for under-represented groups in the population due to non-response to the survey, all counts and percentages were weighted using post-stratification [20]. Post-stratification involves adjusting the sampling weights so that they sum to the population sizes within each post-stratum. In practice, we obtained the distribution of the resident adult population of Italy by first-level NUTS statistical region, gender, and age group as of 1 January 2022 (see Table S1 in the Supplementary Materials) and post-stratified sampling weights in order to obtain a sample distribution fully in line with the target population (see Table S2 in the Supplementary Materials). Unweighted results (that is, not adjusted via post-stratification) are presented in Tables S3–S4 and Figures S1–S4 in the Supplementary Materials for thoroughness.
Differences in sociodemographic characteristics, opinion on vaccination policies, voting intention, and use of alternative medicine according to COVID-19 vaccine uptake status were investigated using the Pearson χ2 test corrected for the survey design with a second-order correction developed by Rao and Scott (1984) [21,22]. Adjusted residuals, that is, Pearson residuals divided by an estimate of their standard error, were analyzed to assess each cell’s contribution to the overall χ2 statistic. In particular, residuals beyond ±3.29 (±z0.001/2) were considered as significantly implicated in the departure from the null hypothesis of independence between variables.
The Kruskal–Wallis test was used to assess whether trust in the Italian government and science was distributed differently in persons accepting, delaying, and refusing COVID-19 vaccination. Post hoc evaluations were performed with the Conover–Iman test for stochastic dominance among multiple pairwise comparisons, using the Bonferroni–Holm method to control the family-wise error rate [23,24]. As a measure of effect size for the Conover–Iman test, we reported the Harrell’s C index (also known as “common language” effect size), which expresses the average probability that an individual from one of the three groups being compared is more trustful than an individual from one of the other two groups [25].
Respondents medically exempt from being vaccinated were excluded from trust and voting intention analyses due to small numbers. All analyses were carried out using the Stata software package, version 17 [26]. The significance level was set at 0.05, and all tests were two-sided.

3. Results

Of the 10,000 respondents to the survey, 8315 (83.2%) claimed to have been vaccinated against COVID-19 as soon as possible and 209 (2.1%) to be exempt from the vaccine, while 803 (8.0%) were “delayers”, i.e., delayed vaccination, and 673 (6.7%) were “no-vaccinators”, i.e., refused to get vaccinated (Figure 1). In the following subsections, results are presented by looking at how “vaccinators”, “delayers”, and “no-vaccinators” were distributed according to each of the potential determinants taken into consideration in the study.

3.1. Sociodemographic Characteristics

As shown in Table 1, COVID-19 vaccine uptake was significantly different in men and women (Rao and Scott-corrected χ2 test = 6.06, p-value < 0.001). In particular, as confirmed by post hoc adjusted residuals, vaccine refusal was significantly more common among females than among males (7.5% vs. 5.8%, respectively). With regard to age (Table 1), vaccine acceptance followed a U-shaped distribution (Rao and Scott-corrected χ2 test = 10.41, p-value < 0.001) in which “delayers” were significantly over-represented in the age groups 25–34 (12.4%) and 35–44 years (11.2%) and under-represented above 64 years (4.3%), while “no-vaccinators” were significantly under-represented below 25 years (3.8%).
Educational attainment was also found to be significantly associated with vaccine uptake (Rao and Scott-corrected χ2 test = 29.65, p-value < 0.001) (Table 1). In particular, as confirmed by post hoc adjusted residuals, people refusing vaccination were over-represented among those with less than a high school diploma (9.3%) and under-represented in those with an academic degree (4.7%); in contrast, respondents with education beyond a master’s degree were significantly more inclined to delay vaccination as compared with those with lower education (11.4%) (Table 1).
Lastly, degree of urbanization was found to be significantly associated with vaccine uptake (Rao and Scott-corrected χ2 test = 18.48, p-value < 0.001) (Table 1). In particular, as confirmed by post hoc adjusted residuals, rural areas had a significantly higher (11.3%) percentage of people delaying vaccination than cities and towns or suburbs (7.4% and 7.6%, respectively).

3.2. Trust in Science

As illustrated in Figure 2, trust in science followed a significantly different distribution according to vaccine uptake status (Kruskal–Wallis test = 1115.77, p-value < 0.001), with significant differences resulting from all post hoc pairwise comparisons across groups (uptake vs. delay: Conover–Iman test = 19.73, p-value < 0.001; uptake vs. refusal: Conover–Iman test = 31.10, p-value < 0.001; delay vs. refusal: Conover–Iman test = 10.68, p-value < 0.001). Indeed, the respondents who exhibited minimal trust (i.e., 1 or 2 points on a scale from 1 to 10) accounted for 18.6% of “no-vaccinators”, 4.7% of “delayers”, and 1.1% of “vaccinators”.
More generally, we estimated a probability of 0.69 (95% CI 0.67–0.71) that a vaccinated individual has a higher trust in science as compared with an individual who puts off getting vaccinated, which increases to 0.83 (95% CI 0.81–0.84) when compared with an individual who rejects vaccination. Lastly, the estimated probability that an individual delaying vaccination has higher trust as opposed to an individual refusing it is 0.68 (95% CI 0.65–0.71).

3.3. Alternative Medicine

As shown in Table 2, the proportion of COVID-19 vaccine acceptance was significantly (and greatly) lower among people who used alternative medicine as their main source of care, as compared with all the others respondents (64.4% vs. 86.3%) (Rao and Scott-corrected χ2 test = 145.56, p-value < 0.001). Consistently, seeing naturopaths, homeopaths, and chiropractors was associated with lower vaccine acceptance (Rao and Scott-corrected χ2 test = 34.25, p-value < 0.001).
Vaccine acceptance was also confirmed to be significantly lower among respondents using aromatherapy (64.4%), homeopathic products (69.2%), and herbal remedies (76.5%) compared with those not using such products or dietary supplements (87.5%).

3.4. Trust in the Current Government

As illustrated in Figure 3, trust in government followed a significantly different distribution according to vaccine uptake status (Kruskal–Wallis test = 883.98, p-value < 0.001), with significant differences resulting from all post hoc pairwise comparisons across groups (uptake vs. delay: Conover–Iman test = 15.25, p-value < 0.001; uptake vs. refusal: Conover–Iman test = 28.41, p-value < 0.001; delay vs. refusal: Conover–Iman test = 11.68, p-value < 0.001). Indeed, the respondents who exhibited minimal trust (i.e., 1 or 2 points on a scale from 1 to 10) accounted for 67.3% of “no-vaccinators”, 40.0% of “delayers”, and 16.5% of “vaccinators”.
More generally, we estimated a probability of 0.65 (95% CI 0.63–0.67) that a vaccinated individual has a higher trust in the government compared with an individual who puts off getting vaccinated, which increases to 0.81 (95% CI 0.79–0.82) when compared with an individual who rejects vaccination. Lastly, the estimated probability that an individual delaying vaccination has higher trust as opposed to an individual refusing it is 0.67 (95% CI 0.65–0.70).

3.5. Voting Intentions

There was evidence of different voting intentions in persons who received, put off, and refused COVID-19 vaccination (Rao and Scott-corrected χ2 test = 18.15, p-value < 0.001). In particular, as illustrated in Figure 4 and confirmed by post hoc adjusted residuals, intention to vote for right-wing parties was significantly lower among people accepting vaccination (24.7%) than among people delaying or refusing it (30.6% and 32.6%, respectively). Conversely, intention to vote for left-wing parties was significantly lower among people delaying or refusing vaccination (9.1% and 5.3%, respectively) than among people accepting it (23.8%). We also found a significantly lower intention to vote for Italy’s independent/anti-establishment party (Movimento 5 Stelle) in those opposing vaccination (8.0%) compared with those accepting or delaying it (13.0% and 14.0%, respectively). Lastly, abstentionism was significantly different in the three study groups (uptake: 12.0%; delay: 19.9%; refusal: 27.3%).

3.6. Policy Instruments

When the study participants were asked about their opinion on the policy instruments that the government should adopt to push the vaccination campaign (Table 3), those most in favor of introducing either mandatory vaccination or penalties were, as expected, the ones who got vaccinated as soon as possible (mandate: 43.6%; penalties: 8.2%), as compared with those who put off vaccination (mandate: 9.7%; penalties: 3.5%) and refused it (mandate: 2.8%; penalties: 1.6%). Conversely, “delayers” and “no-vaccinators” were more in favor of the principle that the government should simply make vaccines and information available, without influencing individual decisions (62.4% and 82.9%, respectively). However, “no-vaccinators” were also against the introduction of positive incentives (12.6%), while such an instrument was more appreciated by “delayers” (24.4%) and, to a lesser extent, by those accepting vaccination (18.5%).

3.7. Self-Declared Motivations

As shown in Table 4, among the 8315 individuals who were vaccinated against COVID-19 as soon as possible, 56.3% did so mainly to avoid severe illness, 19.0% to protect dear ones’, 11.8% from a sense of civic duty, 9.3% to return to normal life, and 3.5% for professional ethics. Among the 803 individuals who intentionally delayed vaccination, 55.0% did so mainly out of fear of side effects, 26.0% for obtaining more information about safety of COVID-19 vaccines, 8.9% for lack of time and/or difficulties accessing healthcare, 5.0% for opposition to vaccines in general, 3.4% because COVID-19 was not perceived as a serious disease, and 1.6% as a form of protest against government. Among the 673 individuals who refused to be vaccinated, 55.6% did so mainly because of fear of side effects, 27.2% due to lack of information about the safety of COVID-19 vaccines, 6.4% because COVID-19 was not perceived as a serious disease, 5.3% for opposition to vaccines in general, 3.4% for fear of needles and/or doctors, and 2.2% as a form of protest against government.

4. Discussion

The present work reports data from a survey conducted in the spring of 2022 on a large national sample of 10,000 adults from Italy. Although the survey contained questions pertaining to several vaccines, this article focuses on the section of the questionnaire pertaining to the COVID-19 vaccine, exploring vaccine refusal, uptake, and hesitancy and its possible drivers in the field of political or personal individual choices.
The pandemic and the availability of COVID-19 vaccines clearly reignited the debate and led to a further flowering of scientific publications on the topic of vaccine hesitancy. Indeed, compared with other vaccine policies, the SARS-CoV-2 immunization campaign added certain elements of complexity [27]: on the one hand, knowledge of the virus was limited, and there were gaps in understanding of the dynamics of its transmission; on the other hand, the need to respond to what was an emergency situation meant that the vaccines had been subjected to clinical trials and then approved rapidly. While several large trials carefully assessed safety and efficacy, there remained some uncertainties in the early post-licensure periods. These included impact on transmission, existence of rare serious adverse events, and their impact on COVID epidemiology in different sectors of the population [28]. These characteristics could reasonably be expected to increase vaccine hesitancy, not just among those who oppose vaccines in general, but also among individuals who are not anti-vaccine in principle but base their decisions on the available information and on the greater or lesser fear of adverse events following immunization.
This research shows that it makes sense to treat the “vaccine-hesitant” population not as one homogeneous category, but as an entity composed of several sub-categories, each showing skepticism toward vaccination for different reasons and with different beliefs and levels of confidence. In our analysis, we distinguished two (macro)categories of vaccine-hesitant people: “delayers” and “no-vaccinators”. Although these two categories shared some common traits (e.g., they are concentrated in the middle age groups and make extensive use of alternative medicine), we also found distinctiveness. “Delayers” were concentrated in the 25–44 age group, were more likely to have a postgraduate degree, showed moderate distrust of science and government, and were largely supportive of government incentives to promote vaccination. In contrast, “no-vaccinators” were predominantly female, had low educational attainment (less than a high school diploma), showed high distrust of science and government, and were unfavorable to the introduction of incentives for those who vaccinate. We have distinguished between two categories only, but future research may go further by segmenting in more detail those on the vaccine acceptance spectrum.
Previous studies established that attitudes toward COVID-19 vaccination can be influenced by sociodemographic variables, such as gender, age, and level of education both in Italy [29,30,31,32,33,34] and worldwide [35,36,37,38,39,40,41].
As some previous results underscore, hesitancy toward the COVID-19 vaccine is more pronounced in females than in men [42,43].
With regard to age, several surveys conducted around the world [36,38,44,45] show that in most countries the propensity to vaccinate against COVID-19 increases with age: older people are expected to be more willing to be vaccinated due to higher risks of severe infection [38], while vaccine uptake is significantly lower among the young [41]. However, some previous surveys conducted in Italy [32,46] paint a different picture compared with other countries. In Italy, the relationship between age groups and propensity to vaccinate against COVID-19 was described as a U-shape [33]: the most likely to vaccinate are those under 35 and over 60, while vaccine refusal is concentrated in the 35–50 age group. The data from our survey confirm the U-shaped relationship already found in Italy. It should be borne in mind when reading this result that in Italy, in early January 2022 a vaccination obligation was introduced for the entire over-50 population.
Previous studies focusing on the COVID-19 vaccine agree that in most countries, including Italy, vaccine hesitancy is significantly associated with lower educational attainment [30,32,38,40,41,47,48]. The findings of our survey paint a somewhat more nuanced picture thanks to our proposed distinction between “delayers” and “no-vaccinators”. Those with a lower educational qualification (less than high school diploma) were more likely to be “no-vaccinators”; those with a university degree (bachelor or master’s degree) were more likely to be vaccinators; those with a qualification beyond master’s degree were less likely to be vaccinators and more likely to be “delayers”. Indeed, it is to be expected that the category of “delayers” is largely made up of individuals who postpone vaccination for one of the following reasons: because they face practical impediments or have low motivation; because of a rational calculation of costs and benefits; and because of free-riding.
Several contributions on vaccine hesitancy have also shown its association with low levels of trust in science [38,44,45,48]. All surveys conducted so far in Italy regarding those opposing vaccination agree on one aspect: those who have higher trust in science are more willing to get vaccinated [29,32,34,46]. This correlation is found in many other countries, with some studies identifying trust in science as the strongest predictor of vaccine acceptance [32,36,38,45]. In this respect, our survey fully confirms the initial expectations: vaccinated individuals had higher values of trust in science; “no-vaccinators” were more likely to have low trust in science; “delayers” were in the middle.
Some previous research surveys conducted worldwide suggest an association between vaccine hesitancy and habitual recourse to complementary and alternative medicine [8,49,50,51,52]. Because, to the best of our knowledge, no scientific survey conducted so far has explored this relationship in Italy, a battery of questions was included in the questionnaire to investigate the respondents’ propensity to resort to natural treatments and alternative medicine (i.e., homeopathy, naturopathy, chiropractic, or osteopathy). Respondents to our questionnaire were thus asked if they used alternative medicine “as their main source of care”. The results are clear, and the correlation is statistically significant: those who use alternative medicine were more likely to be “delayers” or “no-vaccinators”. In short, the Italian case seems to confirm what has already been shown in other countries.
An added value of our survey is that it included some questions on what we might call “political orientation”. A first question concerned trust in the national government in charge. At the time the survey was administered (the spring of 2022), the Draghi government (a coalition government defined as one of “national unity” and supported by all major parties except the right-wing party of Fratelli d’Italia) was in office.
The results of this survey confirm that in Italy, as well as in other countries, certain “political variables” are intertwined with attitudes toward vaccination [32,44,45,48]. Trust toward the government was low among “delayers”, and even lower among “no-vaccinators”.
A second political variable concerned voting intentions and party identification. The question was formulated as follows: “If there were to be political elections tomorrow, which party would you vote for”? Previous surveys conducted in Italy investigated the link between vaccination attitudes and political orientation, asking respondents for generic placement on the right–left axis [41,52,53]. In this survey, respondents were asked to indicate a party specifically and were also given the option to define themselves as “not voting”, since the area of abstentionism is acquiring an increasingly relevant role in Italian politics [54].
Voters of Fratelli d’Italia (a far-right party) and Movimento 5 Stelle (an independent/anti-establishment party) were over-represented among “delayers”. “No-vaccinators” would have voted more frequently for Fratelli d’Italia or other right-wing parties that were not in government when the survey was carried out, and those who had no intention to vote were more likely to be “delayers” and even more to be “no-vaccinators”. It can therefore be argued that the willingness to vaccinate is conditioned by the individuals’ attitude toward authority, institutions, and democratic rules of play. In other words, choosing not to get vaccinated can take on a political, protesting value. However, turning to the dimension of policy instruments (more details on this in the next paragraph), although “delayers” and even more “no-vaccinators” were against both mandatory vaccination and penalties (for those who do not vaccinate), “no-vaccinators” were less sensitive than “delayers” to positive incentives (for those who vaccinate). This finding can be a good starting point to advance some policy recommendations for public decision makers.
As previously mentioned, a third political variable concerned the opinion toward the “policy instruments” that the government can use to promote the vaccination campaign. Indeed, policy makers can choose from a variety of policy instruments, which can be placed on a “ladder of intrusiveness” [55,56,57], starting from voluntary tools (simple information and persuasion), through material incentives and disincentives, to highly coercive tools, such as the introduction of the vaccination mandate. An emerging strand in the literature is interested in understanding—depending on the specific vaccine and social context—the effects of different instruments on vaccination behaviors [3,58,59]. With the intention of contributing to this debate, the statements on governance and instruments that should be adopted in health emergencies with which the participants most agreed were analyzed.
As might have been expected, those most in favor of introducing mandatory vaccination or penalties for the unvaccinated were “vaccinators”; such measures were decidedly less supported by “delayers” and even less by “no-vaccinators”. Instead, the latter two categories were more in favor of the principle that the government should simply make vaccines and information available, without influencing individual decisions. However, “no-vaccinators” were also against the introduction of positive incentives, whilst such an instrument was appreciated by “delayers”. Hence, it is among delayers that we are most likely to find a higher concentration of both “fence-sitters” and “calculating” individuals since—as mentioned earlier—both of these profiles are more sensitive to the introduction of incentives.
Figures from our survey could help further understand why people refuse vaccinations and what people who are hesitant (“delayers” in our survey) think. The majority of people who declared that they had been vaccinated as soon as possible, not only gave reasons related to the evaluation of the benefits, but also showed a strong sense of collective responsibility. Among “delayers”, motivations related to calculation prevailed. Constraints included lack of trust toward vaccines in general, hostility toward the government and, residually, complacency. A similar profile characterized the “no-vaccinators”, but with double the percentages for reasons related to complacency and hostility toward the government.

Strengths and Limitations

In this research, we distinguished the study sample into three categories: individuals who were in favor of the vaccine (and vaccinated as soon as possible), individuals who intentionally postponed vaccination (whom we called “delayers”), and those who—more than a year after the start of the vaccination campaign—had not been vaccinated (whom we called “no-vaccinators”). As shown before, most surveys conducted so far simply distinguish between two categories (individuals in favor versus against the vaccine). Therefore, the distinction into three categories represents the first added value of the present analysis. This tripartite classification makes it possible to grasp the different gradations of vaccine aversion and explore the various determinants that fuel reluctance to vaccinate.
With respect to what we already know about the Italian context, it should be noted that most of the surveys conducted so far regarding COVID-19 vaccines have used non-representative samples [29,32,34,60,61,62,63,64]. Only a few published studies used a nationally representative sample [46], while some others used regionally representative samples [33,65]. None of them, however, were based on a number of respondents as large as ours.
Last but not least, previous studies in countries other than Italy found an association between political orientation and attitudes toward vaccination [36,37,38,66,67,68,69,70]. However, the relationship between “political variables” and vaccination behavior is still little explored—with a few exceptions [41,53]—in Italy. For this reason, our survey investigated the opinions of respondents with reference to both politics (the degree of trust in the current government; the political party with which they identified) and policy (which policy instruments were considered most appropriate to promote vaccination). Having included these “political variables” in the analysis is a further element of originality for the present research.
We acknowledge that this work also has some limitations. First, being a cross-sectional study, it only provides statistical associations between variables and does not enable causal inferences. Second, despite the sample being chosen to be representative of Italy’s demographics, this was an online paid survey that may have attracted people to receive some extra income, leading to a possible over-representation of lower socioeconomic classes. Third, we did not investigate household income, religion, and other sensitive social characteristics that may have jeopardized the size, power, and representativeness of our sample.

5. Conclusions

This article about political beliefs and attitudes toward COVID-19 vaccines contains findings and suggestions characterized by a broad scope that can be extended to other vaccination campaigns.
For a vaccination campaign to be successful, it is essential to segment the target population according to different orientations toward vaccination [71]. Since acceptance and refusal of vaccines are highly context-dependent [8] and each vaccine is unique, it is necessary to estimate on a case-by-case basis the proportions of the different profiles of people accepting, refusing, or delaying vaccinations. Only detailed population mapping can in fact enable policy makers to select the most effective and appropriate policy instruments. It is plausible that each category of “hesitant” individuals—depending on the reasons they defer or reject the vaccine—is sensitive toward some policy instruments but insensitive toward others. An economic incentive, just to give an example, will be motivating for “calculator” individuals, but not for those who oppose the vaccine on ideological grounds or to express distrust of the current government. This implies that some instruments may be found to be costly economically and/or politically but at the same time poorly effective overall. This is something that policy makers should consider when shaping vaccine strategies and choosing policy instruments.
Further research on this topic should employ machine learning algorithms for classification, such as random forests and support vector networks, in order to bypass parametric assumptions for multiple regression and identify clusters of subjects sharing some common features who are likely to either receive, delay, or refuse vaccination.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vaccines11040839/s1, Table S1: Resident adult population of Italy by NUTS statistical region, gender, and age group at 1 January 2022 (n = 49,783,836); Table S2: Relative distribution of the OBVIOUS sample (n = 10,000) and Italy’s adult population at 1 January 2022 (n = 49,783,836) by NUTS statistical region, gender, and age group. Discrepancies between observed weights and expected weights to be obtained via stratified sampling are quantified as the difference between the relative contributions of each stratum in the study sample vs. the target population; Table S3: Sociodemographic characteristics of the study sample, overall and by COVID-19 vaccine uptake status. Counts and percentages are unweighted, that is, not adjusted via post-stratification; Table S4: Reasons for receiving COVID-19 vaccination as soon as possible, putting off getting vaccinated, and refusing to get vaccinated. Counts and percentages are unweighted, that is, not adjusted via post-stratification; Figure S1: COVID-19 vaccine uptake in the study sample (n = 10,000) between January 2021 and April/May 2022, overall and by NUTS statistical region. Percentages are unweighted, that is, not adjusted via post-stratification; Figure S2: Trust in science scored on a scale from a minimum of 1 to a maximum of 10, by COVID-19 vaccine uptake status. Percentages are unweighted, that is, not adjusted via post-stratification; Figure S3: Trust in the Italian government scored on a scale from a minimum of 1 to a maximum of 10, by COVID-19 vaccine uptake status. Percentages are unweighted, that is, not adjusted via post-stratification; Figure S4: Voting intention as of April/May 2022 by COVID-19 vaccine uptake status. Percentages are unweighted, that is, not adjusted via post-stratification.

Author Contributions

Conceptualization, S.P., F.T., A.C., G.L.F., M.M., A.S., G.S., Z.D.V. and F.S.; methodology, A.C., G.L.F., M.M., A.S., G.S., Z.D.V. and F.S.; formal analysis, J.L. (Jacopo Lenzi); investigation, A.C., G.L.F., M.M., A.S., G.S., Z.D.V. and F.S.; data curation, J.L. (Jacopo Lenzi); writing—original draft preparation, D.G., S.P. and F.T.; writing—review and editing, D.G., A.C., G.L.F., M.M., A.S., G.S., Z.D.V., F.S., S.P., F.T., J.L. (Julie Leask) and H.J.L.; supervision, D.G., J.L. (Jacopo Lenzi) and M.P.F. All authors have read and agreed to the published version of the manuscript.

Funding

This study is a product of the OBVIOUS PROJECT, which was funded by GSK Global (Grant Number: 043-2021) and the University of Bologna.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, anonymized data from Dynata was collected in accordance with Italian and European Laws.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

All data is provided in the manuscript.

Conflicts of Interest

Julie Leask has received funding from the World Health Organization for research and consultancy. Heidi J. Larson received a grant for the Vaccine Confidence Project from Merch, J&J, and GSK. The remaining authors declare no conflict of interest.

Appendix A

  • What is your gender?
    A.
    Male
    B.
    Female
    C.
    Non-binary
    D.
    Prefer not to answer
  • Please indicate your date of birth: DD/MM/YYYY
  • Which region do you live in?
    A.
    Abruzzo
    B.
    Basilicata
    C.
    Calabria
    D.
    Campania
    E.
    Emilia-Romagna
    F.
    Friuli-Venezia Giulia
    G.
    Lazio
    H.
    Liguria
    I.
    Lombardia
    J.
    Marche
    K.
    Molise
    L.
    Piemonte
    M.
    Puglia
    N.
    Sardegna
    O.
    Sicilia
    P.
    Toscana
    Q.
    Trentino-Alto Adige
    R.
    Umbria
    S.
    Valle d’Aosta
    T.
    Veneto
  • Please state your highest level of formal education:
    A.
    Elementary/Middle School diploma
    B.
    High School diploma (high school, art/technical/professional institute, teacher training college)
    C.
    University degree (pre-reform, first or second level, single-cycle) or academic diploma
    D.
    Post-graduate degree (advanced training course, university master’s degree, specialization school, PhD)
  • What is your current occupation?
    A.
    Student
    B.
    Doctor
    C.
    Other healthcare professional
    D.
    Law enforcement
    E.
    Teacher
    F.
    Employed (other than the above categories)
    G.
    Unemployed
    H.
    Retired
  • Who do you live with?
    A.
    I live alone
    B.
    I live with a partner
    C.
    I live with my family of origin
    D.
    Other
  • With the financial resources available to you (from personal or family income), are you able to meet the needs of your current living conditions?
    A.
    Level 1 (with great difficulty)
    B.
    Level 2 (with some difficulty)
    C.
    Level 3 (fairly easily)
    D.
    Level 4 (very easily)
  • Do you have difficulty completing daily tasks such as going to the doctor or shopping due to a physical/psychological/sensory disability?
    A.
    Yes
    B.
    No
  • Please indicate your weight: I_I_I_I kg
  • Please indicate your height in centimeters: I_I_I_I cm
  • Please indicate if you suffer from any of the following diseases:
    A.
    Chronic respiratory diseases (including severe asthma, bronchopulmonary dysplasia, cystic fibrosis, and chronic obstructive pulmonary disease-COPD)
    B.
    Chronic cardiovascular diseases, including congenital and acquired heart diseases
    C.
    Diabetes
Answer:
A.
Yes
B.
No
12.
In which of the following facilities did you receive most of your vaccinations?
A.
Hospital
B.
Pharmacy
C.
Family doctor
D.
Vaccination hub
E.
At home
F.
At work
13.
If you could choose, in which facility/place would you prefer to receive a vaccination?
A.
at the hospital
B.
at the pharmacy
C.
from your family doctor
D.
at a vaccination hub
E.
at home
F.
at your workplace
14.
What do your family and friends think about vaccinations?
A.
level 1 (strongly disagree)
B.
level 2 (disagree)
C.
level 3 (somewhat disagree)
D.
level 4 (somewhat agree)
E.
level 5 (agree)
F.
level 6 (strongly agree)
15.
Choose the statement below that best reflects your opinion:
A.
The government should provide vaccines and only provide information without trying to influence individual choices.
B.
The government should provide incentives for those who vaccinate, without imposing any obligation.
C.
The government should impose penalties for those who choose not to vaccinate.
D.
In situations of a health emergency, it is right for the government to mandate vaccinations for citizens.
16.
If there were parliamentary elections tomorrow, which party would you vote for?
A.
Forza Italia
B.
Fratelli d’Italia
C.
Italia Viva
D.
Lega
E.
Five Star Movement
F.
Democratic Party
G.
More Europe/Action
H.
Other left-wing parties
I.
Other center parties
J.
Other right-wing parties
K.
I would not vote
L.
I don’t know/I prefer not to answer
17.
Using the scale below, indicate how much trust you have in the current national government? 1 minimal trust, 10 maximum trust
1 2 3 4 5 6 7 8 9 10
18.
Using the scale below, indicate how much trust you have in science? 1 minimal trust, 10 maximum trust
1 2 3 4 5 6 7 8 9 10
19.
Regarding vaccination against COVID-19, which of the following best describes your situation? (THREE CHOICES)
A.
I vaccinated myself immediately when it was my turn.
B.
I chose to voluntarily postpone vaccination.
C.
I did not get vaccinated.
D.
I am exempt from vaccination (I have an official medical certification)
20.
What were the main reasons for your decision to vaccinate against COVID-19? Indicate no more than three reasons, in order of importance
A.
To avoid getting seriously ill
B.
To protect my loved ones
C.
For civic duty
D.
For professional duty/ethics
E.
To return to a normal life
21.
What were the main reasons for your decision to voluntarily postpone vaccination against COVID-19? Indicate no more than three reasons, in order of importance
A.
Fear of adverse reactions to the vaccine
B.
Lack of time and/or inconvenience of booking and administering the vaccine
C.
To gather more information about the safety of this vaccine
D.
Because I am against vaccines in general
E.
Because Covid is not a serious illness
F.
To protest against the government
22.
What were the main reasons for your decision not to vaccinate against COVID-19? Choose no more than three reasons, in order of importance
A.
Concerns about adverse reactions to the vaccine
B.
Fear of needles and/or doctors
C.
Distrust of anti-COVID vaccines because we know too little about them
D.
Because I am against vaccines in general
E.
Covid is not a serious illness
F.
To protest against the government
23.
Do you use alternative medicine (homeopathy, naturopathy, chiropractic, osteopathy) as a primary source of treatment?
A.
Yes.
B.
No.
24.
In the past year, have you consulted any of the following healthcare professionals for your health problems?
A.
Naturopath.
B.
Osteopath.
C.
Chiropractor.
D.
Homeopath.
E.
None of these.
25.
In the past year, have you used:
A.
Herbal products.
B.
Supplements (e.g. protein, vitamin, or mineral).
C.
Aromatherapy (e.g. essential oils).
D.
Homeopathic products.
E.
None of these.

References

  1. World Health Organization. Agenda, Policy & Strategy, Immunization, Vaccines and Biologicals, Strategic Advisory Group of Experts on Immunization. Understanding the Behavioural and Social Drivers of Vaccine Uptake WHO Position Paper–May 2022. Available online: https://www.who.int/publications/i/item/who-wer9720-209-224 (accessed on 6 February 2023).
  2. World Health Organization. Ten Threats to Global Health in 2019. Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed on 31 January 2023).
  3. Dubé, E.; Vivion, M.; MacDonald, N.E. Vaccine Hesitancy, Vaccine Refusal and the Anti-Vaccine Movement: Influence, Impact and Implications. Expert Rev. Vaccines 2015, 14, 99–117. [Google Scholar] [CrossRef] [PubMed]
  4. Betsch, C.; Böhm, R.; Chapman, G.B. Using Behavioral Insights to Increase Vaccination Policy Effectiveness. Policy Insights Behav. Brain Sci. 2015, 2, 61–73. [Google Scholar] [CrossRef]
  5. MacDonald, N.E.; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015, 33, 4161–4164. [Google Scholar] [CrossRef] [PubMed]
  6. Thomson, A.; Robinson, K.; Vallée-Tourangeau, G. The 5As: A Practical Taxonomy for the Determinants of Vaccine Uptake. Vaccine 2016, 34, 1018–1024. [Google Scholar] [CrossRef] [PubMed]
  7. Betsch, C.; Schmid, P.; Heinemeier, D.; Korn, L.; Holtmann, C.; Böhm, R. Beyond Confidence: Development of a Measure Assessing the 5C Psychological Antecedents of Vaccination. PLoS ONE 2018, 13, e0208601. [Google Scholar] [CrossRef]
  8. Dubé, È.; Ward, J.K.; Verger, P.; MacDonald, N.E. Vaccine Hesitancy, Acceptance, and Anti-Vaccination: Trends and Future Prospects for Public Health. Annu. Rev. Public Health 2021, 42, 175–191. [Google Scholar] [CrossRef]
  9. Salomoni, M.G.; Di Valerio, Z.; Gabrielli, E.; Montalti, M.; Tedesco, D.; Guaraldi, F.; Gori, D. Hesitant or Not Hesitant? A Systematic Review on Global COVID-19 Vaccine Acceptance in Different Populations. Vaccines 2021, 9, 873. [Google Scholar] [CrossRef]
  10. Maietti, E.; Reno, C.; Sanmarchi, F.; Montalti, M.; Fantini, M.P.; Gori, D. Are psychological status and trust in information related to vaccine hesitancy during COVID-19 pandemic? A latent class and mediation analyses in Italy. Hum. Vaccines Immunother. 2022, 18, 2157622. [Google Scholar] [CrossRef]
  11. Gust, D.A.; Kennedy, A.; Shui, I.; Smith, P.J.; Nowak, G.; Pickering, L.K. Parent Attitudes Toward Immunizations and Healthcare Providers. Am. J. Prev. Med. 2005, 29, 105–112. [Google Scholar] [CrossRef]
  12. Keane, M.T.; Walter, M.V.; Patel, B.I.; Moorthy, S.; Stevens, R.B.; Bradley, K.M.; Buford, J.F.; Anderson, E.L.; Anderson, L.P.; Tibbals, K.; et al. Confidence in Vaccination: A Parent Model. Vaccine 2005, 23, 2486–2493. [Google Scholar] [CrossRef]
  13. Leask, J.; Kinnersley, P.; Jackson, C.; Cheater, F.; Bedford, H.; Rowles, G. Communicating with Parents about Vaccination: A Framework for Health Professionals. BMC Pediatr. 2012, 12, 154. [Google Scholar] [CrossRef] [PubMed]
  14. Benin, A.L.; Wisler-Scher, D.J.; Colson, E.; Shapiro, E.D.; Holmboe, E.S. Qualitative Analysis of Mothers’ Decision-Making About Vaccines for Infants: The Importance of Trust. Pediatrics 2006, 117, 1532–1541. [Google Scholar] [CrossRef] [PubMed]
  15. Leask, J. Target the Fence-Sitters. Nature 2011, 473, 443–445. [Google Scholar] [CrossRef] [PubMed]
  16. Hershey, J.C.; Asch, D.A.; Thumasathit, T.; Meszaros, J.; Waters, V.V. The Roles of Altruism, Free Riding, and Bandwagoning in Vaccination Decisions. Organ. Behav. Hum. Decis. Process. 1994, 59, 177–187. [Google Scholar] [CrossRef]
  17. Dynata Panel Book. Available online: https://www.dynata.com (accessed on 31 January 2023).
  18. Jain, D.E.; Yadav, A. Marketing and Technology: Role of Technology in Modern Marketing. IOSR J. Bus. Manag. 2017, 19, 49–53. [Google Scholar] [CrossRef]
  19. Adjei Boakye, E.; Fedorovich, Y.; White, M.; Vohra, S.; Volle, M.; Osazuwa-Peters, N.; Gerend, M.A. Rural-Urban Disparities in HPV Vaccination Coverage Among Adolescents in the Central Part of the State of Illinois, USA. J. Community Health 2022, 48, 24–29. [Google Scholar] [CrossRef]
  20. Levy, P.S.; Lemeshow, S. Sampling of Populations: Methods and Applications; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2008; ISBN 978-0-470-37459-7. [Google Scholar]
  21. Rao, J.N.K.; Scott, A.J. On Chi-Squared Tests for Multiway Contingency Tables with Cell Proportions Estimated from Survey Data. Ann. Stat. 1984, 12, 46–60. [Google Scholar] [CrossRef]
  22. Sribney, W.M. svy7: Two-way contingency tables for survey or clustered data. Stata Tech. Bull. 1998, 45, 33–49. [Google Scholar]
  23. Conover, W.; Iman, R. Multiple-Comparisons Procedures; Informal Report; Office of Scientific and Technical Information (OSTI): Oak Ridge, TN, USA, 1979. [Google Scholar]
  24. Holm, S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979, 6, 65–70. [Google Scholar]
  25. Conroy, R.M. What Hypotheses Do “Nonparametric” Two-Group Tests Actually Test? Stata J. 2012, 12, 182–190. [Google Scholar] [CrossRef]
  26. StataCorp. Stata Statistical Software: Release 17; StataCorp LLC.: College Station, TX, USA, 2021. [Google Scholar]
  27. Borgonovi, F.; Andrieu, E. Bowling Together by Bowling Alone: Social Capital and COVID-19. Soc. Sci. Med. 2020, 265, 113501. [Google Scholar] [CrossRef] [PubMed]
  28. Manski, C. Vaccination Planning under Uncertainty, with Application to COVID-19; National Bureau of Economic Research: Cambridge, MA, USA, 2021; p. w28446. [Google Scholar]
  29. Giuliani, M.; Ichino, A.; Bonomi, A.; Martoni, R.; Cammino, S.; Gorini, A. Who Is Willing to Get Vaccinated? A Study into the Psychological, Socio-Demographic, and Cultural Determinants of COVID-19 Vaccination Intentions. Vaccines 2021, 9, 810. [Google Scholar] [CrossRef] [PubMed]
  30. Montalti, M.; Rallo, F.; Guaraldi, F.; Bartoli, L.; Po, G.; Stillo, M.; Perrone, P.; Squillace, L.; Dallolio, L.; Pandolfi, P.; et al. Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy. Vaccines 2021, 9, 366. [Google Scholar] [CrossRef] [PubMed]
  31. Di Valerio, Z.; Montalti, M.; Guaraldi, F.; Tedesco, D.; Nreu, B.; Mannucci, E.; Monami, M.; Gori, D. Trust of Italian Healthcare Professionals in COVID-19 (Anti-SARS-COV-2) Vaccination. Ann. Ig. 2022, 34, 217–226. [Google Scholar] [PubMed]
  32. Santirocchi, A.; Spataro, P.; Costanzi, M.; Doricchi, F.; Rossi-Arnaud, C.; Cestari, V. Predictors of the Intention to Be Vaccinated against COVID-19 in a Sample of Italian Respondents at the Start of the Immunization Campaign. J. Pers. Med. 2022, 12, 111. [Google Scholar] [CrossRef] [PubMed]
  33. Reno, C.; Maietti, E.; Fantini, M.P.; Savoia, E.; Manzoli, L.; Montalti, M.; Gori, D. Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy. Vaccines 2021, 9, 378. [Google Scholar] [CrossRef]
  34. Simione, L.; Vagni, M.; Gnagnarella, C.; Bersani, G.; Pajardi, D. Mistrust and Beliefs in Conspiracy Theories Differently Mediate the Effects of Psychological Factors on Propensity for COVID-19 Vaccine. Front. Psychol. 2021, 12, 683684. [Google Scholar] [CrossRef]
  35. Neumann-Böhme, S.; Varghese, N.E.; Sabat, I.; Barros, P.P.; Brouwer, W.; van Exel, J.; Schreyögg, J.; Stargardt, T. Once We Have It, Will We Use It? A European Survey on Willingness to Be Vaccinated against COVID-19. Eur. J. Health Econ. 2020, 21, 977–982. [Google Scholar] [CrossRef]
  36. Aw, J.; Seng, J.J.B.; Seah, S.S.Y.; Low, L.L. COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries. Vaccines 2021, 9, 900. [Google Scholar] [CrossRef]
  37. Kerr, J.R.; Schneider, C.R.; Recchia, G.; Dryhurst, S.; Sahlin, U.; Dufouil, C.; Arwidson, P.; Freeman, A.L.; van der Linden, S. Correlates of Intended COVID-19 Vaccine Acceptance across Time and Countries: Results from a Series of Cross-Sectional Surveys. BMJ Open 2021, 11, e048025. [Google Scholar] [CrossRef]
  38. Lindholt, M.F.; Jørgensen, F.; Bor, A.; Petersen, M.B. Public Acceptance of COVID-19 Vaccines: Cross-National Evidence on Levels and Individual-Level Predictors Using Observational Data. BMJ Open 2021, 11, e048172. [Google Scholar] [CrossRef] [PubMed]
  39. Sallam, M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef] [PubMed]
  40. Troiano, G.; Nardi, A. Vaccine hesitancy in the era of COVID-19. Public Health 2021, 194, 245–251. [Google Scholar] [CrossRef]
  41. Borga, L.G.; Clark, A.E.; D’Ambrosio, C.; Lepinteur, A. Characteristics Associated with COVID-19 Vaccine Hesitancy. Sci. Rep. 2022, 12, 12435. [Google Scholar] [CrossRef] [PubMed]
  42. Miraglia del Giudice, G.; Folcarelli, L.; Napoli, A.; Corea, F.; Angelillo, I.F. The Collaborative Working Group COVID-19 Vaccination Hesitancy and Willingness among Pregnant Women in Italy. Front. Public Health 2022, 10, 995382. [Google Scholar] [CrossRef] [PubMed]
  43. Morales, D.X.; Beltran, T.F.; Morales, S.A. Gender, Socioeconomic Status, and COVID-19 Vaccine Hesitancy in the US: An Intersectionality Approach. Sociol. Health Illn. 2022, 44, 953–971. [Google Scholar] [CrossRef]
  44. Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A Global Survey of Potential Acceptance of a COVID-19 Vaccine. Nat. Med. 2021, 27, 225–228. [Google Scholar] [CrossRef]
  45. Lazarus, J.V.; Wyka, K.; White, T.M.; Picchio, C.A.; Rabin, K.; Ratzan, S.C.; Parsons Leigh, J.; Hu, J.; El-Mohandes, A. Revisiting COVID-19 Vaccine Hesitancy around the World Using Data from 23 Countries in 2021. Nat. Commun. 2022, 13, 3801. [Google Scholar] [CrossRef]
  46. Palamenghi, L.; Barello, S.; Boccia, S.; Graffigna, G. Mistrust in Biomedical Research and Vaccine Hesitancy: The Forefront Challenge in the Battle against COVID-19 in Italy. Eur. J. Epidemiol. 2020, 35, 785–788. [Google Scholar] [CrossRef]
  47. Guaraldi, F.; Montalti, M.; Di Valerio, Z.; Mannucci, E.; Nreu, B.; Monami, M.; Gori, D. Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey. Vaccines 2021, 9, 460. [Google Scholar] [CrossRef]
  48. Steinert, J.I.; Sternberg, H.; Prince, H.; Fasolo, B.; Galizzi, M.M.; Büthe, T.; Veltri, G.A. COVID-19 Vaccine Hesitancy in Eight European Countries: Prevalence, Determinants, and Heterogeneity. Sci. Adv. 2022, 8, eabm9825. [Google Scholar] [CrossRef] [PubMed]
  49. Attwell, K.; Navin, M.C.; Lopalco, P.L.; Jestin, C.; Reiter, S.; Omer, S.B. Recent Vaccine Mandates in the United States, Europe and Australia: A Comparative Study. Vaccine 2018, 36, 7377–7384. [Google Scholar] [CrossRef] [PubMed]
  50. Hornsey, M.J.; Lobera, J.; Díaz-Catalán, C. Vaccine Hesitancy Is Strongly Associated with Distrust of Conventional Medicine, and Only Weakly Associated with Trust in Alternative Medicine. Soc. Sci. Med. 2020, 255, 113019. [Google Scholar] [CrossRef] [PubMed]
  51. Gerretsen, P.; Kim, J.; Caravaggio, F.; Quilty, L.; Sanches, M.; Wells, S.; Brown, E.E.; Agic, B.; Pollock, B.G.; Graff-Guerrero, A. Individual Determinants of COVID-19 Vaccine Hesitancy. PLoS ONE 2021, 16, e0258462. [Google Scholar] [CrossRef]
  52. Soveri, A.; Karlsson, L.C.; Antfolk, J.; Lindfelt, M.; Lewandowsky, S. Unwillingness to Engage in Behaviors That Protect against COVID-19: The Role of Conspiracy Beliefs, Trust, and Endorsement of Complementary and Alternative Medicine. BMC Public Health 2021, 21, 684. [Google Scholar] [CrossRef]
  53. Cadeddu, C.; Sapienza, M.; Castagna, C.; Regazzi, L.; Paladini, A.; Ricciardi, W.; Rosano, A. Vaccine Hesitancy and Trust in the Scientific Community in Italy: Comparative Analysis from Two Recent Surveys. Vaccines 2021, 9, 1206. [Google Scholar] [CrossRef]
  54. Bordignon, F.; Ceccarini, L. Where Has the Protest Gone? Populist Attitudes and Electoral Flows in Italian Political Turmoil. Ital. J. Elect. Stud. QOE-IJES 2021, 84, 41–64. [Google Scholar] [CrossRef]
  55. Nuffield Council on Bioethics. Public Health: Ethical Issues; Nuffield Council on Bioethics: London, UK, 2007. [Google Scholar]
  56. Giubilini, A. The Ethics of Vaccination; Wellcome Trust—Funded Monographs and Book Chapters; Palgrave Pivot: Cham, Switzerland, 2019; ISBN 978-3-030-02067-5. [Google Scholar]
  57. Profeti, S.; Toth, F.; Climbing the “Ladder of Intrusiveness”. The Italian Government’s Strategy to Push the COVID-19 Vaccination Coverage Further. Available online: https://ssrn.com/abstract=4158436 (accessed on 4 January 2023).
  58. Attwell, K.; Smith, D.T.; Ward, P.R. ‘The Unhealthy Other’: How Vaccine Rejecting Parents Construct the Vaccinating Mainstream. Vaccine 2018, 36, 1621–1626. [Google Scholar] [CrossRef]
  59. Evans, W.D.; French, J. Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing. Vaccines 2021, 9, 319. [Google Scholar] [CrossRef]
  60. Baccolini, V.; Renzi, E.; Isonne, C.; Migliara, G.; Massimi, A.; De Vito, C.; Marzuillo, C.; Villari, P. COVID-19 Vaccine Hesitancy among Italian University Students: A Cross-Sectional Survey during the First Months of the Vaccination Campaign. Vaccines 2021, 9, 1292. [Google Scholar] [CrossRef]
  61. Caserotti, M.; Girardi, P.; Rubaltelli, E.; Tasso, A.; Lotto, L.; Gavaruzzi, T. Associations of COVID-19 Risk Perception with Vaccine Hesitancy over Time for Italian Residents. Soc. Sci. Med. 2021, 272, 113688. [Google Scholar] [CrossRef] [PubMed]
  62. Del Riccio, M.; Boccalini, S.; Rigon, L.; Biamonte, M.A.; Albora, G.; Giorgetti, D.; Bonanni, P.; Bechini, A. Factors Influencing SARS-CoV-2 Vaccine Acceptance and Hesitancy in a Population-Based Sample in Italy. Vaccines 2021, 9, 633. [Google Scholar] [CrossRef] [PubMed]
  63. Salerno, L.; Craxì, L.; Amodio, E.; Lo Coco, G. Factors Affecting Hesitancy to MRNA and Viral Vector COVID-19 Vaccines among College Students in Italy. Vaccines 2021, 9, 927. [Google Scholar] [CrossRef]
  64. Tagini, S.; Brugnera, A.; Ferrucci, R.; Priori, A.; Compare, A.; Parolin, L.; Pravettoni, G.; Silani, V.; Poletti, B. Behind the Scenes of COVID-19 Vaccine Hesitancy: Psychological Predictors in an Italian Community Sample. Vaccines 2022, 10, 1158. [Google Scholar] [CrossRef]
  65. Barbieri, V.; Wiedermann, C.J.; Lombardo, S.; Ausserhofer, D.; Plagg, B.; Piccoliori, G.; Gärtner, T.; Wiedermann, W.; Engl, A. Vaccine Hesitancy during the Coronavirus Pandemic in South Tyrol, Italy: Linguistic Correlates in a Representative Cross-Sectional Survey. Vaccines 2022, 10, 1584. [Google Scholar] [CrossRef] [PubMed]
  66. Baumgaertner, B.; Carlisle, J.E.; Justwan, F. The Influence of Political Ideology and Trust on Willingness to Vaccinate. PLoS ONE 2018, 13, e0191728. [Google Scholar] [CrossRef]
  67. Reiter, P.L.; Pennell, M.L.; Katz, M.L. Acceptability of a COVID-19 Vaccine among Adults in the United States: How Many People Would Get Vaccinated? Vaccine 2020, 38, 6500–6507. [Google Scholar] [CrossRef]
  68. Ward, J.K.; Alleaume, C.; Peretti-Watel, P.; Peretti-Watel, P.; Seror, V.; Cortaredona, S.; Launay, O.; Raude, J.; Verger, P.; Beck, F.; et al. The French Public’s Attitudes to a Future COVID-19 Vaccine: The Politicization of a Public Health Issue. Soc. Sci. Med. 2020, 265, 113414. [Google Scholar] [CrossRef]
  69. Debus, M.; Tosun, J. Political Ideology and Vaccination Willingness: Implications for Policy Design. Policy Sci. 2021, 54, 477–491. [Google Scholar] [CrossRef]
  70. Latkin, C.A.; Dayton, L.; Yi, G.; Konstantopoulos, A.; Boodram, B. Trust in a COVID-19 Vaccine in the U.S.: A Social-Ecological Perspective. Soc. Sci. Med. 2021, 270, 113684. [Google Scholar] [CrossRef]
  71. Recio-Román, A.; Recio-Menéndez, M.; Román-González, M.V. Global Vaccine Hesitancy Segmentation: A Cross-European Approach. Vaccines 2021, 9, 617. [Google Scholar] [CrossRef] [PubMed]
Figure 1. COVID-19 vaccine uptake in the study sample between January 2021 and April/May 2022 (n = 10,000), overall and by NUTS statistical region. Percentages were post-stratified by using the distribution of Italy’s resident adult population by NUTS region, gender, and age group as of 1 January 2022. Notes: Northwestern Italy includes Piedmont, Aosta Valley, Lombardy, and Liguria; Northeastern Italy includes Trentino-South Tyrol, Veneto, Friuli-Venezia Giulia, and Emilia-Romagna; Central Italy includes Tuscany, Umbria, Marche, and Lazio; Southern Italy includes Abruzzo, Molise, Campania, Apulia, Basilicata, and Calabria; Insular Italy includes Sicily and Sardinia. Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Figure 1. COVID-19 vaccine uptake in the study sample between January 2021 and April/May 2022 (n = 10,000), overall and by NUTS statistical region. Percentages were post-stratified by using the distribution of Italy’s resident adult population by NUTS region, gender, and age group as of 1 January 2022. Notes: Northwestern Italy includes Piedmont, Aosta Valley, Lombardy, and Liguria; Northeastern Italy includes Trentino-South Tyrol, Veneto, Friuli-Venezia Giulia, and Emilia-Romagna; Central Italy includes Tuscany, Umbria, Marche, and Lazio; Southern Italy includes Abruzzo, Molise, Campania, Apulia, Basilicata, and Calabria; Insular Italy includes Sicily and Sardinia. Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Vaccines 11 00839 g001
Figure 2. Trust in science scored on a scale from a minimum of 1 to a maximum of 10, by COVID-19 vaccine uptake status. Percentages were post-stratified by using the distribution of Italy’s resident adult population by NUTS region, gender, and age group as of 1 January 2022. Notes: Cumulative frequencies are displayed with the aid of area charts in the background. Trust among vaccine-exempt individuals is not displayed due to small numbers (n = 209). Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Figure 2. Trust in science scored on a scale from a minimum of 1 to a maximum of 10, by COVID-19 vaccine uptake status. Percentages were post-stratified by using the distribution of Italy’s resident adult population by NUTS region, gender, and age group as of 1 January 2022. Notes: Cumulative frequencies are displayed with the aid of area charts in the background. Trust among vaccine-exempt individuals is not displayed due to small numbers (n = 209). Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Vaccines 11 00839 g002
Figure 3. Trust in the Italian government scored on a scale from a minimum of 1 to a maximum of 10, by COVID-19 vaccine uptake status. Percentages were post-stratified by using the distribution of Italy’s resident adult population by NUTS region, gender, and age group as of 1 January 2022. Notes: Cumulative frequencies are displayed with the aid of area charts in the background. Trust among vaccine-exempt individuals is not displayed due to small numbers (n = 209). Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Figure 3. Trust in the Italian government scored on a scale from a minimum of 1 to a maximum of 10, by COVID-19 vaccine uptake status. Percentages were post-stratified by using the distribution of Italy’s resident adult population by NUTS region, gender, and age group as of 1 January 2022. Notes: Cumulative frequencies are displayed with the aid of area charts in the background. Trust among vaccine-exempt individuals is not displayed due to small numbers (n = 209). Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Vaccines 11 00839 g003
Figure 4. Voting intention as of April/May 2022 by COVID-19 vaccine uptake status. Percentages were post-stratified by using the distribution of Italy’s resident adult population by NUTS region, gender, and age group as of 1 January 2022. Notes: Voting intention among vaccine-exempt individuals is not displayed due to small numbers (n = 209); FdI, Fratelli d’Italia (Brothers of Italy); FI, Forza Italia (Forward Italy); PD, Partito Democratico (Democratic Party); +E, Più Europa (More Europe); Az, Azione (Action); M5S, Movimento 5 Stelle (Five Star Movement); IV, Italia Viva (Italy Alive). Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Figure 4. Voting intention as of April/May 2022 by COVID-19 vaccine uptake status. Percentages were post-stratified by using the distribution of Italy’s resident adult population by NUTS region, gender, and age group as of 1 January 2022. Notes: Voting intention among vaccine-exempt individuals is not displayed due to small numbers (n = 209); FdI, Fratelli d’Italia (Brothers of Italy); FI, Forza Italia (Forward Italy); PD, Partito Democratico (Democratic Party); +E, Più Europa (More Europe); Az, Azione (Action); M5S, Movimento 5 Stelle (Five Star Movement); IV, Italia Viva (Italy Alive). Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Vaccines 11 00839 g004
Table 1. Sociodemographic characteristics of the study sample, overall and by COVID-19 vaccine uptake status. Counts and percentages were obtained by weighting all observed values with post-stratification weights based on the distribution of Italy’s resident adult population by NUTS region, gender, and age group.
Table 1. Sociodemographic characteristics of the study sample, overall and by COVID-19 vaccine uptake status. Counts and percentages were obtained by weighting all observed values with post-stratification weights based on the distribution of Italy’s resident adult population by NUTS region, gender, and age group.
CharacteristicAll
(n = 10,000)
Vaccinated as Soon
as Possible
(n = 8315)
Put Off Getting
Vaccinated
(n = 803)
Refused to Get
Vaccinated
(n = 673)
Vaccine-Exempt
(n = 209)
p-Value
Gender <0.001
    Male4823 (100.0%)4051 (84.0%)356 (7.4%)281 (5.8%) (−)135 (2.8%) (+)
    Female5158 (100.0%)4251 (82.4%)445 (8.6%)389 (7.5%) (+)73 (1.4%) (−)
    Non-binary13 (100.0%)9 (69.2%)1 (7.7%)3 (23.1%)0 (0.0%)
    Prefer not to say6 (100.0%)4 (66.7%)1 (16.7%)0 (0.0%)1 (16.7%)
Age group, y <0.001
    18–24824 (100.0%)709 (86.0%)61 (7.4%)31 (3.8%) (−)23 (2.8%)
    25–341254 (100.0%)997 (79.5%) (−)155 (12.4%) (+)70 (5.6%)32 (2.6%)
    35–441461 (100.0%)1125 (77.0%) (−)164 (11.2%) (+)127 (8.7%)45 (3.1%)
    45–541884 (100.0%)1527 (81.1%)166 (8.8%)157 (8.3%)34 (1.8%)
    55–641756 (100.0%)1503 (85.6%)135 (7.7%)99 (5.6%)19 (1.1%)
    ≥652821 (100.0%)2454 (87.0%) (+)122 (4.3%) (−)189 (6.7%)56 (2.0%)
Place of residence degree of urbanization <0.001
    City (densely populated area)3910 (100.0%)3317 (84.8%) (+)291 (7.4%)243 (6.2%)59 (1.5%)
    Town or suburb (intermediate density area)4687 (100.0%)3931 (83.9%)354 (7.6%)331 (7.1%)71 (1.5%) (−)
    Rural area (thinly populated area)1403 (100.0%)1067 (76.1%) (−)158 (11.3%) (+)99 (7.1%)79 (5.6%) (+)
Educational attainment <0.001
    Less than high school diploma1487 (100.0%)1218 (81.9%)119 (8.0%)139 (9.3%) (+)11 (0.7%) (−)
    High school diploma5742 (100.0%)4794 (83.5%)458 (8.0%)404 (7.0%)86 (1.5%) (−)
    Academic degree1987 (100.0%)1722 (86.7%) (+)137 (6.9%)93 (4.7%) (−)35 (1.8%)
    Post-graduate/Doctorate degree784 (100.0%)581 (74.1%) (−)89 (11.4%) (+)37 (4.7%)77 (9.8%) (+)
(+) Adjusted residual ≥3.29 (≥z0.001/2), that is, frequency is significantly greater than what would be expected if the null hypothesis of independence was true. (−) Adjusted residual ≤3.29 (≤z0.001/2), that is, frequency is significantly lower than what would be expected if the null hypothesis of independence was true. Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Table 2. Use of alternative medicine in the study sample, overall and by COVID-19 vaccine uptake status. Counts and percentages were obtained by weighting all observed values with post-stratification weights based on the distribution of Italy’s resident adult population by NUTS region, gender, and age group.
Table 2. Use of alternative medicine in the study sample, overall and by COVID-19 vaccine uptake status. Counts and percentages were obtained by weighting all observed values with post-stratification weights based on the distribution of Italy’s resident adult population by NUTS region, gender, and age group.
CharacteristicAll
(n = 10,000)
Vaccinated as Soon
as Possible
(n = 8315)
Put Off Getting
Vaccinated
(n = 803)
Refused to Get
Vaccinated
(n = 673)
Vaccine-Exempt
(n = 209)
p-Value
Use of homeopathy, naturopathy, chiropractic or osteopathy as the main source of care <0.001
    Yes1439 (100.0%)927 (64.4%) (−)217 (15.1%) (+)187 (13.0%) (+)108 (7.5%) (+)
    No8561 (100.0%)7388 (86.3%) (+)586 (6.8%) (−)486 (5.7%) (−)101 (1.2%) (−)
Visit to one of the following practitioners over the last year <0.001
    Osteopath 773 (100.0%)636 (82.3%)81 (10.5%)35 (4.5%)21 (2.7%)
    Homeopath388 (100.0%)251 (64.7%) (−)61 (15.7%) (+)38 (9.8%)38 (9.8%) (+)
    Naturopath233 (100.0%)135 (57.9%) (−)46 (19.7%) (+)29 (12.4%) (+)23 (9.9%) (+)
    Chiropractor219 (100.0%)153 (69.9%) (−)27 (12.3%)14 (6.4%)25 (11.4%) (+)
    None of the above8387 (100.0%)7140 (85.1%) (+)588 (7.0%) (−)557 (6.6%)102 (1.2%) (−)
Use of one of the following products over the last year <0.001
    Supplements (e.g., proteins, vitamins, minerals)5300 (100.0%)4419 (83.4%)410 (7.7%)387 (7.3%)84 (1.6%) (−)
    Herbal remedies757 (100.0%)579 (76.5%) (−)90 (11.9%) (+)57 (7.5%)31 (4.1%) (+)
    Homeopathic products419 (100.0%)290 (69.2%) (−)63 (15.0%) (+)33 (7.9%)33 (7.9%) (+)
    Aromatherapy (e.g., essential oils)239 (100.0%)154 (64.4%) (−)38 (15.9%) (+)19 (7.9%)28 (11.7%) (+)
    None of the above3285 (100.0%)2873 (87.5%) (+)202 (6.1%) (−)177 (5.4%) (−)33 (1.0%) (−)
(+) Adjusted residual ≥3.29 (≥z0.001/2), that is, frequency is significantly greater than what would be expected if the null hypothesis of independence was true. (−) Adjusted residual ≤3.29 (≤z0.001/2), that is, frequency is significantly lower than what would be expected if the null hypothesis of independence was true. Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Table 3. Opinion on vaccination policies in the study sample, overall and COVID-19 vaccine uptake status. Counts and percentages were obtained by weighting all observed values with post-stratification weights based on the distribution of Italy’s resident adult population by NUTS region, gender, and age group.
Table 3. Opinion on vaccination policies in the study sample, overall and COVID-19 vaccine uptake status. Counts and percentages were obtained by weighting all observed values with post-stratification weights based on the distribution of Italy’s resident adult population by NUTS region, gender, and age group.
AnswerAll
(n = 10,000)
Vaccinated as Soon
as Possible
(n = 8315)
Put Off Getting
Vaccinated
(n = 803)
Refused to Get
Vaccinated
(n = 673)
Vaccine-Exempt
(n = 209)
Governments must make vaccines mandatory during health emergencies3733 (37.3%)3626 (43.6%) (+)78 (9.7%) (−)19 (2.8%) (−)10 (4.8%) (−)
Governments should restrict themselves to making vaccines available and providing information, without influencing individual decisions3659 (36.6%)2471 (29.7%) (−)501 (62.4%) (+)558 (82.9%) (+)129 (61.7%) (+)
Governments must offer incentives to those who get vaccinated, but without imposing any vaccine mandate1878 (18.8%)1539 (18.5%)196 (24.4%)85 (12.6%) (−)58 (27.8%) (+)
Governments must use penalties for those who decide not to get vaccinated730 (7.3%)679 (8.2%) (+)28 (3.5%) (−)11 (1.6%) (−)12 (5.7%)
(+) Adjusted residual ≥3.29 (≥z0.001/2), that is, frequency is significantly greater than what would be expected if the null hypothesis of independence was true. (−) Adjusted residual ≤3.29 (≤z0.001/2), that is, frequency is significantly lower than what would be expected if the null hypothesis of independence was true. Notes: Rao and Scott-corrected χ2 test of independence between opinion and uptake is equal to 138.97 (p-value < 0.001). Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Table 4. Reasons for receiving COVID-19 vaccination as soon as possible, putting off getting vaccinated, and refusing vaccination. Counts and percentages were obtained by weighting all observed values with post-stratification weights based on the distribution of Italy’s resident adult population by NUTS region, gender, and age group.
Table 4. Reasons for receiving COVID-19 vaccination as soon as possible, putting off getting vaccinated, and refusing vaccination. Counts and percentages were obtained by weighting all observed values with post-stratification weights based on the distribution of Italy’s resident adult population by NUTS region, gender, and age group.
AnswerAllImportance Ranking
1st2nd3rd>3rd
Vaccinated as soon as possible
    Avoiding severe illness8315 (100.0%)4681 (56.3%)929 (11.2%)688 (8.3%)2017 (24.3%)
    Protecting dear ones8315 (100.0%)1583 (19.0%)3095 (37.2%)1087 (13.1%)2550 (30.7%)
    Sense of civic duty8315 (100.0%)984 (11.8%)1371 (16.5%)2045 (24.6%)3915 (47.1%)
    Returning to normal life8315 (100.0%)773 (9.3%)770 (9.3%)1730 (20.8%)5042 (60.6%)
    Professional ethics8315 (100.0%)294 (3.5%)313 (3.8%)471 (5.7%)7237 (87.0%)
Put off vaccination
    Fear of side effects803 (100.0%)442 (55.0%)96 (12.0%)37 (4.6%)228 (28.4%)
    Obtaining more info about safety803 (100.0%)209 (26.0%)236 (29.4%)49 (6.1%)309 (38.5%)
    Lack of time and/or difficulties of access803 (100.0%)72 (8.9%)36 (4.5%)64 (8.0%)631 (78.6%)
    Opposition to vaccines in general803 (100.0%)40 (5.0%)73 (9.1%)67 (8.3%)623 (77.6%)
    COVID-19 not a serious disease803 (100.0%)27 (3.4%)43 (5.4%)75 (9.3%)658 (81.9%)
    Protest against government803 (100.0%)13 (1.6%)21 (2.6%)45 (5.6%)724 (90.2%)
Refused vaccination
    Fear of side effects673 (100.0%)374 (55.6%)111 (16.5%)45 (6.7%)143 (21.2%)
    Lack of information about safety673 (100.0%)183 (27.2%)261 (38.8%)49 (7.3%)180 (26.7%)
    COVID-19 not a serious disease673 (100.0%)43 (6.4%)26 (3.9%)90 (13.4%)514 (76.4%)
    Opposition to vaccines in general673 (100.0%)36 (5.3%)27 (4.0%)66 (9.8%)544 (80.8%)
    Fear of needles and/or doctors673 (100.0%)23 (3.4%)20 (3.0%)14 (2.1%)616 (91.5%)
    Protest against government673 (100.0%)15 (2.2%)26 (3.9%)60 (8.9%)572 (85.0%)
Notes: Respondents were asked to pick three reasons in order of importance. Abbreviations: COVID-19, coronavirus disease 2019; NUTS, Nomenclature of Territorial Units for Statistics.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gori, D.; Capodici, A.; La Fauci, G.; Montalti, M.; Salussolia, A.; Soldà, G.; Di Valerio, Z.; Scognamiglio, F.; Fantini, M.P.; Leask, J.; et al. COVID-19 Vaccine Refusal and Delay among Adults in Italy: Evidence from the OBVIOUS Project, a National Survey in Italy. Vaccines 2023, 11, 839. https://doi.org/10.3390/vaccines11040839

AMA Style

Gori D, Capodici A, La Fauci G, Montalti M, Salussolia A, Soldà G, Di Valerio Z, Scognamiglio F, Fantini MP, Leask J, et al. COVID-19 Vaccine Refusal and Delay among Adults in Italy: Evidence from the OBVIOUS Project, a National Survey in Italy. Vaccines. 2023; 11(4):839. https://doi.org/10.3390/vaccines11040839

Chicago/Turabian Style

Gori, Davide, Angelo Capodici, Giusy La Fauci, Marco Montalti, Aurelia Salussolia, Giorgia Soldà, Zeno Di Valerio, Francesca Scognamiglio, Maria Pia Fantini, Julie Leask, and et al. 2023. "COVID-19 Vaccine Refusal and Delay among Adults in Italy: Evidence from the OBVIOUS Project, a National Survey in Italy" Vaccines 11, no. 4: 839. https://doi.org/10.3390/vaccines11040839

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop